Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 21, 2020

View Archived Issues

Metacrine reports phase I data on FXR agonist MET-642

Interim analysis update on remestemcel-L study in COVID-19 ARDS

Phase II study of BN-Brachyury in chordoma shows signs of clinical activity

Olinvacimab plus pembrolizumab shows clinical benefit in phase Ib study in mTNBC

DZD-4205 demonstrates efficacy in phase I/II JACKPOT8 study in PTCL

Discovery of new PDIA1 inhibitor with antitumor activity in models of multiple myeloma

Chiesi Farmaceutici divulges new P2X3 receptor antagonists

Sage Therapeutics synthesizes CYP46A1 inhibitors

Kallyope identifies new FFAR1 agonists

Korea Pharma describes JAK1 inhibitors

University of California, Oakland patents modified ZIVK-based products for cancer

Preliminary phase I/II data for ZN-c5 monotherapy in ER-positive/HER2-negative breast cancer

Triumeq shown to slow down progression of MND in mice

Tumors, metastases activate mTOR in different ways

Soricimed to explore utility of SOR-C13 for COVID-19

FDA approves Orgovyx for advanced prostate cancer

FDA issues EUA for Moderna's mRNA-1273 for COVID-19

Phase III studies of faricimab in DME meet primary endpoint

FDA issues complete response letter for inclisiran

Qu Biologics to evaluate potential of QBKPN to prevent and treat SARS-CoV-2 infection

XEN-496 shows comparable PK data to that of retigabine

Nanoform announces first human dosing with nanoformed drug

European Commission approves Palforzia to treat peanut allergy

LACEWING study of Xospata in FLT3mut+ AML does not meet primary endpoint

FDA approves Xpovio for multiple myeloma after at least one prior therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...